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Type 4 secretion system
TRAF6Helicobacter pylori colonises the gastric epithelial cells of half of the world's population and represents a risk
factor for gastric adenocarcinoma. In gastric epithelial cells H. pylori induces the immediate early response
transcription factor nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB) and the innate
immune response.We show thatH. pylori induces in a type IV secretion system-dependent (T4SS) and cytotoxin
associated gene A protein (CagA)-independent manner a transient activation of the inhibitor of NF-κB (IκBα)
kinase (IKK)-complex. IKKα and IKKβ expression stabilises the regulatory IKK complex subunit NF-κB essential
modulator (NEMO). We provide evidence for an intimate mutual control of the IKK complex by mitogen-
activated protein kinase kinase kinase 3 (MEKK3) and transforming growth factor β activated kinase 1 (TAK1).
TAK1 interacts transiently with the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 6
(TRAF6). Protein modiﬁcations in the TAK1 molecule, e.g. TAK1 autophosphorylation and K63-linked
ubiquitinylation, administer NF-κB signalling including transient recruitment of the IKK-complex. Overall, our
data uncover H. pylori-induced interactions and protein modiﬁcations of the IKK complex, and its upstream
regulatory factors involved in NF-κB activation.
© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The human pathogenHelicobacter pylori colonises the gastric epithe-
lium and could induce gastric diseases [1]. Virulent strains of the gram-
negative, microaerophilic bacterium H. pylori carry a cag pathogenicity
island (cagPAI). It encodes the T4SS, which translocates the effector
protein CagA and possibly other molecules into epithelial host cells [2].
Infection of the gastric epithelial cell layer by H. pylori induces
inﬂammatory responses in the host by releasing chemotactic
chemokines which recruit monocytes and granulocytes to the site of
infection [3]. Thus, gastric epithelial cells actively participate in inﬂam-
mation and mucosal immunity during initial and persistent H. pylori
infection. The host antimicrobial response provoked by colonising
H. pylori involves NF-κB, which regulates, along with other signalling
pathways, the activation of genes involved in the innate immune
response. Activation of NF-κB is fast and leads to the release of
chemokines, e.g. interleukin 8 (IL-8) from colonised epithelial cells
[4–8]. Systematic mutagenesis revealed that some cagPAI genes were
required for induction of IL-8 and also showed that CagA is dispensablel Internal Medicine, Otto von
rg, Germany. Tel.: +49 391 67
n).
. Open access under CC BY-NC-ND license.for IL-8 release [9]. Further it has been shown that H. pylori induces NF-
κB activity very fast in a T4SS-dependent, but CagA-independent
manner [6,10–13].
The heterodimeric NF-κB transcription factor composed of p50
and RelA becomes translocated into the nucleus in response to
H. pyloriwithin a few minutes. A prerequisite for nuclear translocation
of NF-κB is the phosphorylation of the NF-κB inhibitor IκBα in a
consensus sequence (DSGXXS: at S32 and S36) by IKKβ [12–14].
Further, tyrosine phosphorylation of IKKβ (Y199) directed by cellular
sarcoma (c-Src) contributes to NF-κB activation [15]. IKKβ is part of the
IKK-complex, which contains two highly homologous kinase subunits,
IKKα and IKKβ, and the regulatory subunit NF-κB essential modulator
(NEMO). Phosphorylation of IκBα is a signal function for K48-linked
ubiquitinylation of IκBα by a cullin-RING ubiquitin ligase [16].
Different eukaryotic factors involved in NF-κB activation inH. pylori-
infection have been described so far, e.g. p21-activated kinase1 (PAK1)
[14,17], NF-κB-inducing kinase (NIK) [14,17,18], TRAF2 [19] and
TRAF6 [18,19], the peptidoglycan recognising nucleotide-binding
oligomerisation domain-containing protein 1 (NOD1) [20], TAK1 and
myeloid differentiation primary response 88 (MyD88) [19], c-Src [15]
and Ca2+/calmodulin-dependent kinase II (CAMKII) [21]. Hitherto, the
mechanism of IKK complex regulation in H. pylori infection is not
resolved [22].
Distinctive microbial macromolecular ligands, such as lipopolysac-
charide (LPS) and ﬂagellin, which bind to toll-like receptors (TLRs)
might not be responsible for activation of NF-κB, because isogenic T4SS
mutant strains of H. pylori omit NF-κB activation. Further, muropeptides
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which bind NOD1 protein, might be also not involved in H. pylori-
induced NF-κB activation [23].
Here, we report that H. pylori induces in a T4SS-dependent, but
CagA-independent manner a transient activation of the IKK complex.
The integrity of the IKK complex is required for phosphorylation of
RelA and IκBα, and the IKK complex assembly stabilises the NEMO
protein. Further, we provide evidence for an intimate mutual control
of the IKK complex by MEKK3 and TAK1. H. pylori induces a transient
recruitment of TRAF6 to TAK1. Protein modiﬁcations of TAK1, e.g. auto-
phosphorylation and K63-linked ubiquitinylation, administer NF-κB
downstream signalling including transient interaction of the IKK
complex with TAK1.
2. Materials and methods
2.1. Cell culture and bacteria
AGS, NCI-N87 (human gastric carcinoma) and SW480 (human
colorectal carcinoma) cells (ATCC) were grown in RPMI 1640 medium
(PAA Laboratories) supplemented with 10% fetal bovine serum (FBS)
and penicillin/streptomycin. Sixteen hours prior to the experiment,
the cell medium was replaced with fresh RPMI 1640 supplemented
with 0.5% FBS.
H. pyloriwild-type (wt) strain P1 and their isogenic mutants P1 cagA
and P1 cagT as well as wild-type (wt) strain G27 and their isogenic
mutants G27 cagA and G27 cagEwere cultured for 48–72 h as described
previously [24,25]. AGS cells were infected at a multiplicity of infection
of 100.
2.2. Antibodies and inhibitors
The description of the antibodies used for the experiments is
provided in Supplementary Table S1.
A derivative of (5Z)-7-oxozeaenol was purchased from AnalytiCon
Discovery and IKK inhibitor VII was from Calbiochem/Merck. Recombi-
nant human TNFα and IL-1βwere purchased from R&D Systems.
2.3. Cell fractionation, immunoprecipitation and immunoblot
Cell lysates were prepared with a modiﬁed RIPA buffer as described
[26]. For ubiquitin detection, inhibitors of ubiquitin and ubiquitin-like
isopeptidases and deubiquitinylases PR-619 (10 μM) (LifeSensors),
N-ethylmaleimide (2 mM) and 1,10-phenantroline (2 mM) (Sigma-
Aldrich)were added to the lysis buffer. Lysateswere boiledwith sample
buffer (50 mM Tris–HCl, pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT,
and 0.1% bromphenol blue) for 5 min. Subcellular fractions of AGS
cells were prepared with the ProteoExtract kit (Calbiochem/Merck).
For immunoprecipitation, cell lysates were incubated with the
antibody overnight at 4 °C. Protein G Dynabeads (Invitrogen Dynal
AS) were used to capture the immunocomplexes.
Proteins in the lysates or immunoprecipitates were separated by
SDS-PAGE and the gel was electrotransferred onto Immobilon-P
transfer polyvinylidene ﬂuoride membranes (Millipore). The blots
were incubated with primary antibodies diluted in 5% non-fat milk
overnight at 4 °C and subsequently with HRP-conjugated anti-rabbit
or anti-mouse secondary antibodies (Jackson ImmunoResearch Labora-
tories). Immunoblots were developed using the enhanced chemilumi-
nescence detection kit Amersham ECL (GE Healthcare).
2.4. Transient transfection
Cells (~105 cells/35 mmdish) were transfected with siRNAs speciﬁc
to IKKα, IKKβ, NEMO, MEKK3 (Eurogentec) and TAK1 (Santa Cruz
Biotechnology) using siLentFect Lipid Reagent (BioRad) in Opti-MEM I
culture medium (Life Technologies) supplemented with 5% FCS. Ascrambled sequence that does not lead to the speciﬁc inhibition of any
known cellular mRNA was purchased from Santa Cruz Biotechnology.
For ectopic expression of proteins, AGS cells (2 × 106 cells/100 mm
dish) were transfected with pCMV-TAK1, pCMV-TAK1(K63W) and
pRK5-HA-Ubiquitin-K63 (Addgene, plasmid 17606, a gift of T. Dawson)
by using Effectene transfection reagent (Qiagen).
2.5. RNA isolation and RT-PCR
Total RNA was extracted with the RNeasy Plus Micro kit (Qiagen).
cDNA was synthesized from 1 μg of RNA using a random hexamer
primer and RevertAid First Strand cDNA Synthesis kit (Fermentas).
cDNA was ampliﬁed as described [26] using the following primers: 5′-
TCCAAAATCAAGTGGGGCGATGCT-3′ (forward) and 5′-CCACCTGGTGCT
CAGTGTGACCC-3′ (reverse) for GAPDH; 5′-GCAGAGAGGAGGACCTGT
TG-3′ (forward) and 5′-ACTGCTTCAGCCCACACTTT-3′ (reverse); 5′-
GAAACAACAGCTGCCTCTCC-3′ (forward) and 5′-TCCTGTACAGCTCCCT
TGCT-3′ (reverse); and 5′-GACAAGGCCTCTGTGAAAGC-3′ (forward)
and 5′-ATCGATCACCTCCTGTTTGG-3′ (reverse) for IKKα, IKKβ and
NEMO, respectively. GAPDH expression served as an internal control.
PCR products were visualized by ethidium bromide staining following
the agarose gel electrophoresis.
2.6. Transactivation assay
AGS cells were seeded onto 24-well plates at a density of 3.5 × 104
cells per well in Opti-MEM I culture medium supplemented with
5% FCS. The Fireﬂy Luciferase plasmid containing three repeats of the
NF-κB binding site from the human immunodeﬁciency virus was mixed
with Renilla Luciferase plasmid in a ratio of 60:1 and co-transfected
with 50 nM of speciﬁc siRNAs against TAK1 or MEKK3 using SureFECT
transfection reagent (SABiosciences). Luciferase activity was estimated
in crude cell lysates using the Dual-Luciferase Reporter Assay System
(Promega) with a Lumat LB 9507 luminometer (Berthold Technologies).
The inducible ﬁreﬂy luciferase activity was normalised relative to
Renilla's activity, and fold changes in stimulated sampleswere calculated
in comparison to non-stimulated cells.
2.7. Statistical analysis
Statistical analysis of the results was performed using the Student's
t-test. The data are expressed as the mean fold changes from at least 3
separate experiments ±SEM with the value of the control arbitrarily
normalised to 1.
3. Results
3.1. IKK complex activity is required for NF-κB activation
We investigated NF-κB regulation in AGS cells infectedwith isogenic
H. pylori P1 strains (wt, cagAor cagT). CagA represents a virulence factor,
which becomes translocated via the T4SS, and the CagT protein is
required for the assembly of the pilus-like T4SS [27].
Infection of AGS cells with isogenic wt and cagA-deﬁcient H. pylori
induced a strong and transient phosphorylation within the activation
loops of IKKα and IKKβ, whereas phosphorylation of NEMO was
sustained (Fig. 1A). Infection with the cagT mutant did not induce
phosphorylation of the IKK complex. Prominent phosphorylation of
IKKα/IKKβ and NEMO in TNFα-treated cells was similar to H. pylori-
infected cells (Fig. 1B). IKK activity is crucial for H. pylori-induced
NF-κB activation, because the selective ATP-competitive IKK
inhibitor VII abrogated IκBα and RelA phosphorylation (Fig. 1C).
The integrity of the IKK complex was not affected in response to
H. pylori infection as demonstrated by co-immunoprecipitation of
IKKα/IKKβ with an antibody against NEMO (Fig. 1D).
Fig. 1. IKK complex activity is required for NF-κB activation. AGS cells were infectedwith the H. pylori P1wt strain or with the cagA or cagTmutants or were stimulated with TNFα for the
indicated periods of time. (A and B) Cell lysates were analysed in an immunoblot using the antibodies against the indicated proteins. Immunostaining of GAPDHwas performed to show
equal protein loading. (C) Cells were treated with 10 μM of IKK inhibitor VII for 30 min prior to infection. (D) Cell lysates were subjected to immunoprecipitation (IP) using anti-NEMO
antibody and immunoprecipitates were analysed in an immunoblot. The sample without antibody (no ab) indicates unspeciﬁc binding to the beads and serves as a control. (E and F)
Subcellular fractions were prepared and analysed in an immunoblot. Immunostainings of GAPDH, occludin and histone H3 were performed to show the purity of the cellular fractions
and equal protein amounts in the samples. The blots shown in each panel comprise data from the same experiment. Full-size blots are presented in Supplementary Fig. 4.
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TNFα-stimulated cells regarding the cellular localisation of the activated
IKK complex, we studied the abundance of the IKK subunits in cytosolic,
membranous and nuclear fractions. As expected, infectionwithH. pylori
or TNFα treatment actuated an accumulation of RelA in the nucleus of
AGS cells within 15 min, but no changes in the localisation of IKK
subunits were detected (Fig. 1E and F).3.2. Integrity of the IKK complex is required for NF-κB activation
The particular involvement of each IKK subunit in NF-κB activation
was investigated by using speciﬁc siRNAs. Treatment of AGS cells with
different amounts of siRNAs against IKKα, IKKβ or NEMO led to a
dose-dependent reduction of IκBα and RelA phosphorylation in
H. pylori infection (Fig. 2A–C). Herein, knockdown of NEMO led to the
Fig. 2. Integrity of the IKK complex is required for NF-κB activation. siRNA-transfected AGS
cells were infected with the H. pylori P1 wt strain for 30 or 60 min, and cell lysates were
analysed in an immunoblot using antibodies as indicated. 15, 30 and 60 nM of IKKα
siRNA (A), IKKβ siRNA (B) or NEMO siRNA (C) were used for transfection. A scrambled
siRNA (30 nM)was used as a control. Quantiﬁcation of immunoblot bandswas performed
using densitometry and the relative phospho-IκBα/GAPDH ratio is indicated. The blots
shown in each panel comprise data from the same experiment. Full-size blots are
presented in Supplementary Fig. 5.
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Thus, the integrity of the IKK complex is strongly required for its
catalytic activity in H. pylori-infected cells. Interestingly, the NEMO
protein abundance was very low in cells treated with speciﬁc siRNAsagainst IKKα or IKKβ (Fig. 2A and B). Similar data have been observed
in H. pylori-infected NCI-N87 and SW480 cells (Fig. S1A and B).
3.3. IKKα/β complex assembly stabilises NEMO
We observed a dramatic loss of the NEMO protein in IKKα- and
IKKβ-deﬁcient cells (Fig. 3A and B). The effect was most prominent in
a double knockdown of IKKα/IKKβ (Fig. 3A). To exclude off-target
effects on NEMO, transfection of AGS cells with 3 different siRNAs
against each of IKKα or IKKβ were performed showing similar results
(Fig. 3B). Quantiﬁcation of NEMO mRNA by RT-PCR indicated that the
decrease of NEMO in cells treated with siRNAs against IKKα or IKKβ
was not due to changes at the transcriptional level (Fig. 3C). Thus, IKK
complex assembly stabilises the regulatory subunit NEMO.
3.4. MEKK3 and TAK1 are required for efﬁcient activation of the IKK
complex
MEKK3 and TAK1 kinases have been shown to transduce signalling
from cytokine receptors to IKK complex activity [28]. Infection of AGS
cells with P1 wt and cagA-deﬁcient mutant of H. pylori induced a tran-
sient phosphorylation (S166) of MEKK3 kinase (Fig. 4A). The functional
consequence of phosphorylation at amino acid S166 in theMEKK3 pro-
tein was not clariﬁed so far. Interestingly, we observed also a slight
phosphorylation of MEKK3 in the cagT-infected cells (Fig. 4A), whereas
in TNFα-stimulated cells, no phosphorylation of MEKK3 was detected
(Fig. 4B). Inducible phosphorylation of TAK1 at critical sites (T184/
T187) in the activation loop peaked at 15 min p.i., whereas the cagT
mutant did not induce TAK1 phosphorylation (Fig. 4A). Similar to the
H. pylori strain P1, we observed an inducible phosphorylation of
MEKK3 and TAK1 in a T4SS-dependent, but CagA-independent manner
by the H. pylori G27 strain (Fig. S2A). TNFα treatment resulted also in
transient, but less strong TAK1 phosphorylation than infection with
H. pylori (Fig. 4B). Studying putative differences of TAK1 and MEKK3
phosphorylation in other cell lines, we observed that H. pylori induced
strong phosphorylation of TAK1 and weak phosphorylation of MEKK3
in NCI-N87 cells, whereas similar phosphorylation of both proteins
was observed in infected SW480 cells (Fig. S2B).
A transient depletion of TAK1 or MEKK3 led to a reduction of IKKα/
IKKβ phosphorylation (27.8% and 71.1%), and IκBα and RelA phosphor-
ylation in H. pylori-stimulated cells (Fig. 4C). Interestingly, depletion of
MEKK3 together with TAK1 had an additive suppressive effect on phos-
phorylation of IKKα/IKKβ (12.5%) (Fig. 4C). Similar data have been
received in H. pylori-infected NCI-N87 and SW480 cells (Fig. S2C and
D). These results suggest that H. pylori-induced activation of NF-κB
involves both kinases (MEKK3 and TAK1). Even more prominent was
the impact of TAK1 or MEKK3 siRNAs on NF-κB transactivation activity
in response to H. pylori infection and TNFα treatment (Fig. 4D). Pre-
treatment of AGS, NCI-N87 and SW480 cells with (5Z)-7-oxozeaenol,
a highly potent inhibitor of TAK1 [29], dose-dependently reduced the
phosphorylation of IKKα/IKKβ, IκBα and RelA in response to H. pylori
(Fig. 4E; Fig. S2E and F), in agreement with the data shown above
about depletion of TAK1 byRNA interference. The inhibitor did not com-
promise the viability of H. pylori (Fig. 4F). Pre-treatment of AGS cells
with the (5Z)-7-oxozeaenol reduced also TNFα- and IL-1β-stimulated
phosphorylation of NF-κB effector molecules (Fig. 4G and H).
3.5. TAK1 interacts with the IKK complex
Investigation of TAK1-associated proteins revealed that IKKα and
IKKβ were co-immunoprecipitated with TAK1 in an inducible manner
in cells infected with P1 wt and cagA, but not with the cagT strain
(Fig. 5A and B). In addition to AGS cells, we observed interaction of
IKKs to TAK1 in P1 wt-infected NCI-N87 and SW480 cells (Fig. S3A
and B). Thus, H. pylori infection induces formation of a protein complex
Fig. 3. IKK complex assembly stabilises NEMO. (A and C) AGS cells were transfected for 48 h either with a mixture of 3 different IKKα- or IKKβ-speciﬁc siRNAs (10 nM of each, 30 nM in
total), or (B) with each of these 3 siRNAs separately (30 nM of each). A scrambled siRNA (30 nM) was used as a control. (A and B) Cell lysates were analysed in an immunoblot using the
antibodies as indicated. Immunostaining of GAPDHwas performed to show equal protein loading in each lane. The relative changes of NEMOwere calculated by comparing the intensity of
the protein bands of NEMO vs. GAPDH and from cells transfected with siRNAs against IKKα or IKKβ vs. scrambled siRNA. (C) Total RNA was isolated and quantitative RT-PCR was
performed. *P b 0.01 compared with the cells transfected with the scrambled siRNA. The blots shown in each of the panels A and B comprise data from the same experiment. Full-size
blots are presented in Supplementary Fig. 6.
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manner.
It has been published that CagAmight interact with TAK1 [30]. Thus,
we analysed the proteins immunoprecipitated by the TAK1 antibody in
detail for the presence of CagA. As shown in Fig. 5A, therewas CagA pro-
tein detected in wt-infected cells after long exposure of the immuno-
blot. In the cagA-infected cells, there was no CagA protein recognised,
indicating that the protein band from the wt-infected cells represents
the CagA protein. Further, we detected the CagA protein in the cagT-
infected cells also after long exposure of the immunoblot (Fig. 5B). Of
note, the cagT mutant expresses the CagA protein, but does not inject
CagA into the epithelial cells due to the non-functional T4SS. This indi-
cates that the observed CagA protein in the TAK1 immunoprecipitation
from lysates of the cagT-infected cells arose from adherent bacteria.
When we performed appropriate controls within the experiment, we
observed surprisingly the CagA protein in the TAK1 immunoprecipita-
tion from the lysate of the H. pylori wt bacteria (only wt + ab), in the
absence of an AGS cell lysate (Fig. 5A, lane 12) or from the lysate
of the cagT bacteria (only cagT + ab) (Fig. 5B, lane 13). In the TAK1
immunoprecipitation from the lysate of the H. pylori cagA bacteria
(only cagA + ab) there was no CagA protein detected (Fig. 5A,
lane 13). Thus, it is curious that the antibody against TAK1
immunoprecipitated to some extent the CagA protein. This is at least
one explanation for the misinterpretation of the data by Lamb et al.
[30] where the same antibody from Santa Cruz has been used for
TAK1 immunoprecipitation. In a reverse immunoprecipitation using a
CagA antibody we could not recognise co-immunoprecipitated TAK1
even after long exposure (Fig. 5C), which supports the data of the
TAK1 immunoprecipitation.
3.6. TAK1 associates transiently with TRAF6
TRAF6, an E3 ligase, has been shown to bind to TAK1 (through TAK1
binding protein TAB2) in response to IL-1β and LPS [31]. In line with
this, inducible TRAF6 recruitment to TAK1 was observed in H. pylori-
infected AGS cells (Fig. 6A). Being most prominent at 30 min p.i.,TAK1–TRAF6 transient association was detected in the H. pylori wt-
and cagA- but not cagT-infected cells (Fig. 6B). Similar to the H. pylori
strain P1, the G27 strain induced recruitment of TRAF6 to TAK1 and
an interaction between TAK1 and IKKα/β in a T4SS-dependent, but
CagA-independent manner (Fig. 6E). In addition to AGS cells, we
observed recruitment of TRAF6 to TAK1 in P1 wt-infected NCI-N87
and SW480 cells (Fig. S3D and E). We also found an increase of K63-
linked ubiquitinylation of TAK1 in AGS cells after overexpression of
TAK1 and ubiquitin-K63 (other lysinesmutated to arginine) in response
to H. pylori (Fig. 6C) and IL-1β (Fig. 6D). TAK1 catalytic activity is
required for ubiquitinylation of TAK1, because ectopic expression of
TAK1(K63W) kinase inactive protein showed no ubiquitinylation in
response to IL-1β (Fig. 6D).
4. Discussion
Pathogens often subvert the innate and adaptive immune response
by secretion of effector molecules via a secretion system directly into
the cytosol of target cells, where the effectors can access the host cell
signalling. Many proteins delivered by pathogens into host cells affect
the regulation of the IKKs, IκBα and the transcription factor RelA [16].
A number of eukaryotic molecules have been described which might
contribute to the regulation of NF-κB activation in H. pylori infection
[22]. Despite these ﬁndings, details about the entire mechanism of
how H. pylori infection promotes the activity of the immediate early
response factor NF-κB are still not well understood. Here, we add
more facets to the apparent complexity of NF-κB regulation in
H. pylori infection by analysing the regulation of the IKK complex and
identifying functional componentswithin theNF-κB signal transmission
(Fig. 7).
H. pylori-induced phosphorylation within the activation loops of
IKKα (S176/S180) and IKKβ (S177/S181) requires the functional T4SS,
but not CagA (Fig. 1). The phosphorylation causes conformational
changes resulting in kinase activation [32]. We show for the ﬁrst time,
that H. pylori promotes NEMO phosphorylation at S376 (Fig. 1). In
previous studies it has been shown that IKKβ, but not IKKα
Fig. 4. TAK1 andMEKK3 are required for efﬁcient activation of the IKK complex and NF-κB. (A–C and E, G, and H) AGS cells were infectedwith theH. pylori P1wt strain orwith the cagA or
cagTmutants or were stimulatedwith TNFα, or IL-1β for the indicated periods of time. Cell lysateswere analysed in an immunoblot using the antibodies as indicated. Immunostainings of
TAK1, RelA, or GAPDH were performed to show equal protein loading. (C) 48 h prior to infection, cells were transfected with 30 nM TAK1, MEKK3 or scrambled siRNAs. (D) Cells were
transfected with Fireﬂy NF-κB and Renilla Luciferase plasmids and co-transfected with 50 nM of TAK1, MEKK3 or scrambled siRNAs. 48 h after transfection, cells were infected with
H. pyloriwt or treated with TNFα for 3 h, and a reporter gene assay was performed. #P b 0.01 compared to the scrambled siRNA-transfected cells. (E, G, and H) Cells were treated with
increasing doses of TAK1 inhibitor (5Z)-7-oxozeaenol for 30 min prior to stimulation. (F) H. pylori P1 wt strain was incubated in RPMI 1640 medium supplemented with increasing
amounts of a (5Z)-7-oxozeaenol derivative for 1 h. The bacterial suspension was serially diluted in PBS and plated onto GC agar supplemented with horse serum, vancomycin,
trimethoprim, nystatin and vitamins. The bacterial colonies were counted after 3-day growth in standardmicroaerophilic conditions. Quantiﬁcation of immunoblot bands was performed
using densitometry and the relative phospho-IKK/GAPDH ratio is indicated. The blots shown in each panel (A–C, E, G and H) comprise data from the same experiment. Full-size blots are
presented in Supplementary Fig. 7.
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blasts [33], and that the phosphorylation of NEMO at orthologous S369
controls intrinsic activity of the IKK complex [34]. Our data indicate that
the pre-assembled IKK complex and its subcellular localisation is not af-
fected in H. pylori infection. In contrast to Hirata et al. [12], we found no
nuclear translocation of IKKα in AGS cells colonised by H. pylori
(Fig. 1E). Interestingly, we show for the ﬁrst time that the integrity ofthe IKK complex is required for NF-κB activation byH. pylori, and deple-
tion of NEMO has the most prominent suppressive effect on NF-κB ac-
tivity. In addition, IKK complex assembly is a prerequisite for the
stability of the regulatory subunit NEMO (Figs. 2 and 3).
The regulation of the IKK complex exerts an extraordinary degree of
connectivity of central signalling pathways and executes cell type- and
stimulus-speciﬁc functions. Studying the intricate interactions and
Fig. 5. TAK1 interacts with the IKK complex in a T4SS-dependentmanner. AGS cells were infectedwith theH. pylori P1wt strain or with the cagA or cagTmutants for the indicated periods
of time. Cell lysates were subjected to immunoprecipitation (IP) using anti-TAK1 antibody (A and B) or anti-CagA antibody (C). The samples without antibody (no ab), without AGS cell
lysate (only wt + ab; only cagA + ab; only cagT + ab), or without AGS cell lysate/bacterial lysate (only buffer + ab) indicate for the speciﬁcity of the IP and serve as controls.
Immunoprecipitates and cell lysates were analysed in an immunoblot using the antibodies as indicated. The blots shown in each panel comprise data from the same experiment. Full-
size blots are presented in Supplementary Fig. 8.
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IKK activation within H. pylori-induced NF-κB signal transmission, we
identiﬁed the kinases MEKK3 and TAK1. MEKK3 plays an essential role
in lysophosphatidic acid-, TNFα- and LPS-induced NF-κB activation
[35–37]. It has been suggested by Yao et al. [28] that MEKK3-
dependent activation of NF-κB involves NEMO, IKKα and IκBα phos-
phorylation, leading to subsequent dissociation of IκBα from NF-κB
without IκBα degradation. We found that infection with H. pylori pro-
moted phosphorylation of MEKK3 at S166, but not at S337 (data not
shown), whereas TNFα did not stimulate S166 phosphorylation
(Fig. 4). Activating autophosphorylation at S184/S187within the activa-
tion loop of TAK1 was induced in H. pylori-infected cells in a T4SS-
dependent, but CagA-independent manner, and in TNFα-stimulatedcells. Transfection of AGS, NCI-N87 and SW480 cells with TAK1-
speciﬁc, together with MEKK3-speciﬁc siRNAs led to a strong reduction
of IKKα/β, IκBα and RelA phosphorylation and suppressed the
transactivation activity of RelA following H. pylori infection. Thus, both
kinases contribute to H. pylori-directed activation of NF-κB. The sup-
pression of NF-κB activationwas prominentwhenwe used the TAK1 ki-
nase inhibitor (5Z)-7-oxozeaenol (Fig. 4). These data are in accordance
with the results of Hirata et al. [19],whichhave demonstrated that TAK1
is required for H. pylori-induced IκBα phosphorylation. In addition to
TAK1 which phosphorylates IKKα/β, also PAK1 contributes to IKK acti-
vation by phosphorylation of IKKα [14]. Thus, H. pylori could induce
NF-κB activation by different contributing pathways/factors. Other
contributing factors like TRAF2, NIK [18], and MyD88 [19] have been
Fig. 6. TAK1 interacts with TRAF6. AGS cells were infectedwith theH. pylori P1wt strain, the cagA or cagTmutants (A–C), with theH. pyloriG27wt strain, the cagA or cagEmutants (E), or
were stimulatedwith TNFα or IL-1β for the indicated periods of time. Cell lysates were subjected to immunoprecipitation (IP) using anti-TAK1 antibody. The samples without IP antibody
(no ab), without AGS cell lysate (only wt + ab; only cagA + ab; only cagE + ab), or without AGS cell lysate/bacterial lysate (only buffer + ab) indicate for the speciﬁcity of the IP and
serve as controls. Immunoprecipitates and cell lysates were analysed in an immunoblot using the antibodies as indicated. (C and D) 24 h prior to infection with the H. pylori wt, or
treatment with TNFα or IL-1β, cells were transfected either with TAK1 or with its kinase-inactive mutant TAK1(K63W) together with HA-tagged ubiquitin K63 plasmids (3 μg of
each). The blots shown in each panel comprise data from the same experiment. Full-size blots are presented in Supplementary Fig. 9.
722 O. Sokolova et al. / Biochimica et Biophysica Acta 1843 (2014) 715–724described previously. Of note, we show now by a variety of experimen-
tal approaches, including siRNA interference, that TAK1 is involved in
H. pylori-induced NF-κB activation; thus, we have to repeal our previous
data in which transient transfection of a dominant negative TAK1 cDNA
had no impact on NF-κB transactivation [17].
TAK1 transiently associates with the IKKs, in a T4SS-dependent, but
CagA-independent manner. The kinetics of the IKK interaction to TAK1
is in front of IκBα and RelA phosphorylation. Further, we provide
experimental evidence that CagA does not interact with TAK1 in
H. pylori-infected cells (Fig. 5).TAK1 forms a complex with TAB1, TAB2 or the structurally related
TAB3 [38], and attracts several additional activators, including apoptosis
signal-regulating kinase 1 (ASK1) [39] and TRAF6. TRAF molecules
represent a group of structurally similar adaptor proteins, which link
the receptors to downstream signalling. TRAF6 transduces signalling
from TLRs and the IL-1β receptor by associating with phosphorylated
IL-1-receptor associated kinase 1 (IRAK1). TRAF6 is regulated by an E2
enzyme complex (Ubc13)/Uev1a) and is capable of autoubiquitinylation.
K63-linked ubiquitin chains of TRAF6 recruit TAB2 and its homologue
TAB3, and thereby TAK1 [38]. Similarly to IL-1β receptor/TLR-dependent
Fig. 7. Activation of IKK complex and NF-κB in H. pylori infection. H. pylori induces in a T4SS-dependent manner MEKK3 phosphorylation and triggers intricate interactions and protein
modiﬁcationswithin the TAK1/TABs complex. Common target of upstream regulatory components and integral part ofH. pylori-induced NF-κB regulation is the IKK complex. Interactions
in the multi-protein complexes coincide with a range of post-translational modiﬁcations (phosphorylation and ubiquitinylation) within their members and its effector molecules (see
explanation in text). TAK1 is not a target of the H. pylori effector protein CagA. TAK1-dependent phosphorylation of IKK promotes subsequent phosphorylation of IKKβ substrate IκBα.
Phosphorylation of IκBα leads to its degradation in the 26S proteasome, NF-κB translocation to the nucleus, and transcription initiation. Protein phosphorylation sites are indicated.
Further, our previous work showed that PAK1 contributes to the activation of the IKK complex.
723O. Sokolova et al. / Biochimica et Biophysica Acta 1843 (2014) 715–724signal transmission, H. pylori induces transient recruitment of TRAF6 to
TAK1 (Fig. 6).H. pylori has to hold a functional T4SS, but not CagA, to elicit
this effect.
Ubiquitinylation plays an important role in NF-κB signalling. K48-
ubiquitinylation is associated with protein degradation and K63-
ubiquitinylation serves as regulatory modiﬁcation [40]. Here, we
observed a transient K63-linked ubiquitinylation of TAK1 on H. pylori
infection (Fig. 6). Putative E3 ligases which ubiquitinylate TAK1
comprise TRAF6 or tripartite motif 8 (TRIM8), which ubiquitinylate
TAK1 at K34 [41] and K158 [42], respectively. Eventually, TRAF6
promotes H. pylori-induced K63-linked ubiquitinylation of TAK1 when
recruited to the TAK1/TABs complex. Since the observed K63-linked
ubiquitinylation of TAK1 on H. pylori infection is transient (Fig. 6), a
putative role of deubiquitinylases remains to be investigated. For the
removal of TAK1 ubiquitinylation, it has been described that USP4
deubiquitinylates TAK1 and negatively regulates IL-1β- and LPS-induced NF-κB [43]. In addition, an Itch–CYLD complex promotes the
transition of K63-linked ubiquitinylation to K48-linked ubiquitinylation
by sequentially cleaving the K63-linked ubiquitin chain and catalysing
K48-linked ubiquitinylation of TAK1 [44]. Lysine 72 has been suggested
as a site for K48-linked ubiquitinylation of TAK1 [45].
In summary, our study provides evidence for an intimate mutual
control of the IKK complex by the kinases MEKK3 and TAK1 in
H. pylori infection. The ﬁndings support a mechanism by which
H. pylori, through the T4SS but not through CagA, promotes MEKK3
and TAK1 phosphorylation, TAK1 ubiquitinylation and the recruit-
ment of the IKK complex promoting NF-κB signalling in the host
cell. In depth clariﬁcation of the underlying mechanisms of
H. pylori-induced NF-κB activation will require further extensive
studies to identify the intricate interactions of upstream regulatory
factors and the protein modiﬁcations important for their biological
functions.
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